Further investigations revealed 18 cancer hotspots [40] mutations in EPHA3, FUBP1, GATA3, MAP2K4, PTEN, RNF43, SF3B1, SMAD2, TP53, and VHL. This evidence concerns the gene SMAD2 and cancer.